Stockscreener 앱 받기
99.67
1.96%
-1.99
시간 외 거래:
99.65
-0.02
-0.02%
Abbott Laboratories 주식(ABT)의 최신 뉴스
Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite Trajectories - Yahoo Finance
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Lobbying Update: $1,150,000 of ABBOTT LABORATORIES lobbying was just disclosed - Quiver Quantitative
Abbott Laboratories stock trades steadily as diagnostics and medical devices underpin earnings momen - Ad-hoc-news.de
Craneware, Abbott Probe Separate Health Data Theft Incidents - BankInfoSecurity
Abbott Laboratories (NYSE:ABT) Faces A Major Medical Device Growth Test - Kalkine Media
ShinyHunters hit medial giant Abbott, disrupting cancer drug research and more - Yahoo Tech
Abbott Investigating Cyberattack Claims From Two Threat Actors - The HIPAA Journal
Healthcare giant Abbott probes two cyber incidents amid extortion claims - Malwarebytes
Abbott Laboratories investigates 2 separate cyber incidents - SC Media
Fairlife dairy cyberattack, ACR Stealer surge, Abbott Labs incidents - LinkedIn
Benchmark reiterates Buy on Abbott Labs stock, cites guidance raise - Investing.com
Abbott Laboratories stock trades steady as diagnostics and medical devices support growth - Ad-hoc-news.de
Cybersecurity News: Fairlife dairy cyberattack, ACR Stealer surge, Abbott Labs incidents - CISO Series
Abbott Laboratories Cybersecurity Breach Analysis: ShinyHunters Attack on Exact Sciences Systems and ShadowByt3$ LabCentral Portal Incident - Rescana
Abbott Investigates Two Separate Cyber Incidents, Says No Operations Affected - Insurance Journal
Abbott Laboratories stock holds firm as diagnostics and medical devices support earnings - ad-hoc-news.de
Medical giant Abbott investigates two cyber incidents as ShinyHunters claims breach - Cybernews
This Dividend ETF Yields 3.2% and Is Beating the Nasdaq-100 This Year - The Motley Fool
Abbott Laboratories (ABT) Stock Faces Margin Squeeze As Net Profit Slide Tests Growth Narrative - simplywall.st
Analysts Are Bullish on Top Healthcare Stocks: Intuitive Surgical (ISRG), Abbott Laboratories (ABT) - The Globe and Mail
Abbott Stock: Bear Trap Over, With Richer Return Prospects (NYSE:ABT) - Seeking Alpha
Abbott Just Showed Its Growth Engine Has More Than One Cylinder - Trefis
Abbott investigates two separate cyber incidents, says no operations affected By Reuters - Investing.com
Abbott investigates two cyber intrusions targeting cancer diagnostics and LabCentral portal - Межа. Новини України.
Abbott investigates two separate cyber incidents, says no operations affected - Reuters
Keysight Invalidates IRS Rule On GILTI, Abbott Says - Law360
US companies face rise in cyber attacks - Reuters
Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating - Moomoo
Abbott probes two cyber incidents amid extortion claims - BleepingComputer
Abbott discloses cyberattack on cancer diagnostics business - MedTech Dive
ABT Reiterated by Piper Sandler -- Price Target Raised to $118 - GuruFocus
Can Abbott Laboratories (NYSE:ABT) Extend Its Dividend Strength? - Kalkine Media
Abbott Laboratories Stock Surges 11% as Company Lifts Full Year Profit Guidance - TIKR.com
Abbott Laboratories Stock (ABT) Moved Up by 3.03% on Jul 17: Drivers Behind the Movement - TradingKey
ABT Q2 Earnings Call Flags Stronger Second-Half Setup - The Globe and Mail
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results - Benzinga
Benchmark reiterates Buy on Abbott Labs stock, keeps $120 target - Investing.com
Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating - Moomoo
Can Abbott Stock Deliver on Its Second-Half Growth Promise? - Trefis
Abbott Laboratories stock could rise 40%+ by 20... - Pluang
JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating - marketscreener.com
Abbott Laboratories: Pick Up This Dividend King Deal Now - Seeking Alpha
Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation - NAI500
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street - Investing.com
What Helped Abbott Laboratories (NYSE:ABT) Raise Full-Year Outlook? - Kalkine Media
Abbott Laboratories (ABT) Could Be 15% Undervalued On Raised 2026 Earnings Outlook - simplywall.st
Why Abbott Stock Jumped Today - The Motley Fool
Abbott Laboratories Earnings Call Signals Broad-Based Momentum - TipRanks
ABT: Abbott Laboratories Exceeds Revenue and EPS Expectations, R - GuruFocus
Abbott Is On Deck to Launch Several New Devices - Morningstar
ABT: Abbott Laboratories Exceeds Expectations and Raises Profit Outlook - GuruFocus
Abbott Laboratories’s Stock Price Soars to $98.83, Enjoying a Robust 10.71% Uptick - Smartkarma
BTIG raises Abbott Labs stock price target to $134 on Q2 strength - Investing.com
Strong Demand and Growth Forecast for Abbott Laboratories (ABT) - GuruFocus
Abbott Laboratories (ABT) Q2 2026 Earnings Call Highlights: Stro - GuruFocus
Abbott (ABT) Lifts 2026 EPS Outlook Amid Business Mix Shift Toward Devices and Diagnostics - Yahoo Finance
Abbott (ABT) Receives Outperform Rating Amid Positive Q2 Results - GuruFocus
1.43%
자본화:
|
볼륨(24시간):